J.P. Morgan 36th Annual Healthcare Investor Conference. San Francisco, CA. January 8-11, 2018.
The 4th Annual Translational Microbiome Conference, Arrowhead Publishers. Boston, MA. April 18-20, 2018.
The 5th World Congress on Targeting Infectious Diseases: Targeting Phage & Antibiotic Resistance. Florence, Italy. May 17-18, 2018.
Microbiome Drug Development Summit: Translating the Human Microbiome from Marvel to Safe & Effective Medicines. Boston, MA. June 19-21, 2018.
The International Society for Viruses of Microorganisms 5th Viruses of Microbes Meeting. Wrocław, Poland. July 9-13, 2018.
Cantor Fitzgerald Global Healthcare Conference. New York, NY. October 1-3, 2018.
The 2nd International Symposium on Antimicrobial Hydrolytic Enzymes. The Rockefeller University. New York, NY. November 6-8, 2018.
Stifel 2017 Healthcare Conference. New York, NY. November 14-15, 2017.
5th Microbiome R&D and Business Collaboration Forum: USA. San Diego, CA. November 2-3, 2017.
Cantor Fitzgerald Healthcare Conference. New York, NY. September 25-27, 2017.
The 22nd Biennial Evergreen Bacteriophage Meeting. Evergreen, WA. August 6-11, 2017.
Bacteriophage Therapy: Scientific and Regulatory Issues. Hosted by the FDA, CBER, NIH NIAID. Rockville, MD. July 10-11, 2017.
Microbiome Drug Development Summit: Translating the Human Microbiome into Effective Therapies. Boston, MA. June 27-29, 2017.
Jefferies 2017 Healthcare Conference. New York, NY. June 6-9, 2017.
ASM Microbe (ASM + ICACAC). New Orleans, LA. June 1-5, 2017.
ICNARA (International Conference on Anti-Caries Remineralizing Agents). NAPA Valley, CA. April 30- May 2, 2017.
J.P. Morgan 35th Annual Healthcare Investor Conference. San Francisco, CA. January 9-13, 2017.
3rd Annual Re-Entering Antibacterial Discovery and Development Summit. Boston, MA. December 7-9, 2016.